APP Pharmaceuticals Acquires Three Products from Nexus
5/23/2012 10:57:14 AM
More...
|
APP Pharmaceuticals Announces Expanded Supply of Methotrexate Injection, USP
3/5/2012 6:14:59 AM
More...
|
APP Pharmaceuticals Announces Approval of Preservative-Free Methotrexate Injection, USP
2/22/2012 7:04:53 AM
More...
|
APP Pharmaceuticals Announces Launch of Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP
2/8/2012 6:52:38 AM
More...
|
The Medicines Company (MDCO) Settles Angiomax(R) (Bivalirudin) Patent Litigations With APP Pharmaceuticals
1/23/2012 7:14:33 AM
More...
|
APP Pharmaceuticals Announces Increased Availability of APP Diprivan(R) and APP Propofol 1%
10/17/2011 9:19:37 AM
More...
|
APP Pharmaceuticals Announces Approval and Launch of Clonidine Hydrochloride Injection
7/11/2011 9:58:48 AM
More...
|
APP Pharmaceuticals Announces Approval of Nafcillin for Injection, USP
7/6/2011 6:46:23 AM
More...
|
APP Pharmaceuticals Invests $38 Million to Expand Its Grand Island, New York Manufacturing Facility; 90 New Jobs Will be Created
6/15/2011 6:30:57 AM
More...
|
APP Pharmaceuticals Named NOVAPLUS(R) Pharmacy Manufacturer of the Year
6/8/2011 10:05:53 AM
More...
|
|